MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/hypertensionaha.123.22457

Медицинская библиотека · Hypertension (Dallas, Tex. : 1979) · 2024

Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in Preeclampsia.

Tan Lunbo, Kluivers Ans C M, Cruz-López Edwyn O, Broekhuizen Michelle, Chen Zhongli, Neuman Rugina I, Schoenmakers Sam, Ruijgrok Liesbeth, van de Velde Daan, de Winter Brenda C M, van den Bogaerdt Antoon J, Lu Xifeng, Danser A H Jan, Verdonk Koen

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Chemerin, an inflammatory adipokine, is upregulated in preeclampsia, and its placental overexpression results in preeclampsia-like symptoms in mice. Statins may lower chemerin.

METHODS

Chemerin was determined in a prospective cohort study in women suspected of preeclampsia and evaluated as a predictor versus the sFlt-1 (soluble fms-like tyrosine kinase-1)/PlGF (placental growth factor) ratio. Chemerin release was studied in perfused placentas and placental explants with or without the statins pravastatin and fluvastatin. We also addressed statin placental passage and the effects of chemerin in chorionic plate arteries.

RESULTS

Serum chemerin was elevated in women with preeclampsia, and its addition to a predictive model yielded significant effects on top of the sFlt-1/PlGF ratio to predict preeclampsia and its fetal complications. Perfused placentas and explants of preeclamptic women released more chemerin and sFlt-1 and less PlGF than those of healthy pregnant women. Statins reversed this. Both statins entered the fetal compartment, and the fetal/maternal concentration ratio of pravastatin was twice that of fluvastatin. Chemerin constricted plate arteries, and this was blocked by a chemerin receptor antagonist and pravastatin. Chemerin did not potentiate endothelin-1 in chorionic plate arteries. In explants, statins upregulated low-density lipoprotein receptor expression, which relies on the same transcription factor as chemerin, and NO release.

CONCLUSIONS

Chemerin is a biomarker for preeclampsia, and statins both prevent its placental upregulation and effects, in an NO and low-density lipoprotein receptor-dependent manner. Combined with their capacity to improve the sFlt-1/PlGF ratio, this offers an attractive mechanism by which statins may prevent or treat preeclampsia.

Для цитирования: Tan Lunbo, Kluivers Ans C M, Cruz-López Edwyn O, Broekhuizen Michelle, Chen Zhongli, Neuman Rugina I, Schoenmakers Sam, Ruijgrok Liesbeth, van de Velde Daan, de Winter Brenda C M, van den Bogaerdt Antoon J, Lu Xifeng, Danser A H Jan, Verdonk Koen. Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in Preeclampsia.. Hypertension (Dallas, Tex. : 1979). 2024. DOI: 10.1161/hypertensionaha.123.22457.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.